Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Food on the Pharmacokinetics of D3S-001 in Healthy Adults
NCT07093398Phase 1Completed
- Sponsor
- D3 Bio
- Start
- Jul 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of elisrasib (2 arms), sponsored by D3 Bio. Primary endpoints: Maximum Observed Concentration at 34 days and Area under the concentration-time curve at 34 days. Started Jul 2025; status: completed.
02
Drugs
elisrasib
Beyond the preview
Go deeper on NCT07093398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07093398.